Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-15 Sale | 2023-06-16 6:40 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $20.86 | $1,251,727 | 688,607 (Indirect Direct) | View |
| 2023-05-22 Sale | 2023-05-24 4:37 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 6,500 | $25.79 | $167,641 | 39,294 (Indirect Direct) | View |
| 2023-05-15 Sale | 2023-05-16 8:32 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 5,000 | $27.17 | $135,864 | 1,500 (Direct) | View |
| 2023-05-15 Sale | 2023-05-16 8:29 pm | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 1,785 | $27.32 | $48,765 | 4,350 (Direct) | View |
| 2023-04-06 Sale | 2023-04-10 6:20 pm | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $17.32 | $1,039,200 | 8,840,750 (Indirect Direct) | View |
| 2023-03-20 Sale | 2023-03-22 7:30 pm | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 64,500 | $18.97 | $1,223,313 | 9,302,644 (Indirect Direct) | View |
| 2023-03-15 Sale | 2023-03-16 6:02 pm | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,084 | $19.5 | $40,638 | 48,753 (Direct) | View |
| 2023-03-15 Sale | 2023-03-16 6:01 pm | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 985 | $19.69 | $19,396 | 56,749 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-14 Exercise | 2023-09-18 4:49 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 521 | $0 | 15,749 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:49 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:48 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 521 | $0 | 10,603 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-09-14 Exercise | 2023-09-18 4:47 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 2,610 | $0 | 57,707 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 5:02 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Bray June Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 5:01 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 4:59 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | MILLER MICHAEL PATRICK Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 4:58 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Option Award | 2023-06-28 4:56 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-26 Other | 2023-06-28 4:56 pm | N/A 2033-06-26 | BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director | 17,000 | $0 | 17,000 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:46 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 521 | $0 | 10,603 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:44 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 521 | $0 | 15,749 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:42 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 521 | $0 | 7,753 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-16 6:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $0.41 | 688,607 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:40 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 62,609 | $0 | 688,607 (Direct) | View |
| 2023-06-14 Exercise | 2023-06-16 6:36 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer | 521 | $0 | 7,492 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:33 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 15,000 | $0 | 32,894 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:32 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 5,000 | $0 | 1,500 (Direct) | View |
| 2023-05-14 Exercise | 2023-05-16 8:29 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks | 5,000 | $0 | 4,350 (Direct) | View |
Ownership | 2023-04-26 3:19 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Aiello Michael James 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-14 11:30 am | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Balasubramanian Suganthi 10% Owner | 0 | $0 | 8,547,750 (Indirect) | View |
Ownership | 2023-04-13 7:52 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Agarwal Rashmi 10% Owner | 0 | $0 | 8,554,945 (Direct) | View |
Ownership | 2023-04-13 7:51 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Agarwal Anesha 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:24 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Sood Pardeep Kumar 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:21 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Sood Alka 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:16 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Patel Krunal Dilip 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 7:14 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Patel Jatin Markand 10% Owner | 0 | $0 | 8,547,750 (Indirect) | View |
Ownership | 2023-04-13 7:12 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Patel Bina Jatin 10% Owner | 0 | $0 | 8,547,750 (Indirect) | View |
Ownership | 2023-04-13 7:10 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Jain Diwakar 10% Owner | 0 | $0 | 8,547,300 (Direct) | View |
Ownership | 2023-04-13 7:08 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Jain Anita 10% Owner | 0 | $0 | 8,547,300 (Direct) | View |
Ownership | 2023-04-13 7:05 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Gupta Tarun K. 10% Owner | 0 | $0 | 8,550,396 (Direct) | View |
Ownership | 2023-04-13 7:03 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Gupta Indu R. 10% Owner | 0 | $0 | 8,550,396 (Direct) | View |
Ownership | 2023-04-13 7:01 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Gibson Marshal D. 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
Ownership | 2023-04-13 6:57 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Agarwal Vipin 10% Owner | 0 | $0 | 8,554,945 (Direct) | View |
Ownership | 2023-04-13 6:55 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Agarwal Akrati 10% Owner | 0 | $0 | 8,546,750 (Indirect) | View |
| 2023-04-06 Exercise | 2023-04-10 6:20 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0.41 | 8,840,750 (Direct) | View |
| 2023-04-06 Exercise | 2023-04-10 6:20 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0 | 8,840,750 (Direct) | View |
| 2023-03-20 Exercise | 2023-03-22 7:30 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $0.41 | 9,302,644 (Direct) | View |
| 2023-03-20 Exercise | 2023-03-22 7:30 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 60,000 | $0 | 9,302,644 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 6:02 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 41,000 | $0 | 48,753 (Direct) | View |
| 2023-03-14 Exercise | 2023-03-16 6:02 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer | 2,084 | $0 | 48,753 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 6:01 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 41,000 | $0 | 56,749 (Direct) | View |
| 2023-03-14 Exercise | 2023-03-16 6:01 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer | 2,084 | $0 | 56,749 (Direct) | View |
| 2023-03-15 Option Award | 2023-03-16 6:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 224,000 | $0 | 8,824,457 (Direct) | View |
| 2023-03-14 Exercise | 2023-03-16 6:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President | 10,437 | $0 | 8,824,457 (Direct) | View |